Common Contracts
92 similar Exclusive Agency Agreement contracts by Histogen Inc., Kitov Pharma Ltd., Predictive Oncology Inc., others
STRICTLY CONFIDENTIAL Arcadia Biosciences, Inc.Exclusive Agency Agreement • August 16th, 2022 • Arcadia Biosciences, Inc. • Agricultural production-crops • New York
STRICTLY CONFIDENTIAL Predictive Oncology Inc.Exclusive Agency Agreement • May 18th, 2022 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
STRICTLY CONFIDENTIAL Histogen Inc. 10655 Sorrento Valley Road, Suite 200 San Diego, CA 92121 Attn: Steven J. Mento, Ph.D., Executive Chairman, Interim President and Chief Executive Officer Dear Dr. Mento:Exclusive Agency Agreement • March 25th, 2022 • Histogen Inc. • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) constitutes the agreement between Histogen Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connect
STRICTLY CONFIDENTIALExclusive Agency Agreement • November 4th, 2021 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Certain confidential information contained in this document, marked by brackets and asterisk, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed.Exclusive Agency Agreement • September 29th, 2021 • ReWalk Robotics Ltd. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This letter agreement (this “Agreement”) constitutes the agreement between ReWalk Robotics Ltd. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company (the “Securities”), including, but not limited to, restructuring of the outstanding warrants of the Company (a “Warrant Restructuring”), during the Term (as hereinafter defined) of this Agreement (each, an “Offering”). The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company
STRICTLY CONFIDENTIAL EyeGate Pharmaceuticals, Inc.Exclusive Agency Agreement • August 10th, 2021 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Intec Pharma Ltd.Exclusive Agency Agreement • July 29th, 2021 • Intec Parent Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Uranium Energy Corp.Exclusive Agency Agreement • April 8th, 2021 • Uranium Energy Corp • Miscellaneous metal ores • New York
STRICTLY CONFIDENTIAL Innovative Payment Solutions, Inc. 19355 Business Center Drive, #9 Northridge, CA 91324 Attn: William Corbett, Chief Executive OfficerExclusive Agency Agreement • March 16th, 2021 • Innovative Payment Solutions, Inc. • Retail-catalog & mail-order houses • New York
This letter agreement (this “Agreement”) constitutes the agreement between Innovative Payment Solutions, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of
STRICTLY CONFIDENTIAL CloudCommerce, Inc.Exclusive Agency Agreement • February 22nd, 2021 • Cloudcommerce, Inc. • Retail-miscellaneous retail • New York
STRICTLY CONFIDENTIAL Fuel Tech, Inc. 27601 Bella Vista Parkway Warrenville, IL 60555-1617 Attn: Vincent J. Arnone, Chief Executive Officer Dear Mr. Arnone:Exclusive Agency Agreement • February 18th, 2021 • Fuel Tech, Inc. • Industrial & commercial fans & blowers & air purifing equip • New York
This letter agreement (this “Agreement”) constitutes the agreement between Fuel Tech, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in conne
STRICTLY CONFIDENTIAL Caladrius Biosciences, Inc.Exclusive Agency Agreement • February 16th, 2021 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • New York
STRICTLY CONFIDENTIAL Cyren Ltd.Exclusive Agency Agreement • February 16th, 2021 • CYREN Ltd. • Services-prepackaged software • New York
STRICTLY CONFIDENTIAL Arch Therapeutics, Inc.Exclusive Agency Agreement • February 12th, 2021 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
STRICTLY CONFIDENTIAL Tyme Technologies, Inc.Exclusive Agency Agreement • February 5th, 2021 • Tyme Technologies, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Citius Pharmaceuticals, Inc.Exclusive Agency Agreement • January 27th, 2021 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL BioSolar, Inc. 27936 Lost Canyon Road, Suite 202 Santa Clarita, CA 91387 Attn: David Lee, Chief Executive OfficerExclusive Agency Agreement • January 25th, 2021 • BioSolar Inc • Unsupported plastics film & sheet • New York
This letter agreement (this “Agreement”) constitutes the agreement between BioSolar, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connec
STRICTLY CONFIDENTIAL Senseonics Holdings, Inc. 20451 Seneca Meadows Parkway Germantown, MD 20876-7005 Attn: Timothy T. Goodnow, Chief Executive OfficerExclusive Agency Agreement • January 19th, 2021 • Senseonics Holdings, Inc. • Industrial instruments for measurement, display, and control • New York
This letter agreement (this “Agreement”) constitutes the agreement between Senseonics Holdings, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwrigh
STRICTLY CONFIDENTIAL Predictive Oncology Inc.Exclusive Agency Agreement • January 12th, 2021 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
STRICTLY CONFIDENTIAL Staffing 360 Solutions, Inc. 641 Lexington Avenue 27th Floor New York, NY 10022 Attn: Brendan Flood, Chief Executive Officer Dear Mr. Flood:Exclusive Agency Agreement • December 31st, 2020 • Staffing 360 Solutions, Inc. • Services-help supply services • New York
This letter agreement (this “Agreement”) constitutes the agreement between Staffing 360 Solutions, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwr
STRICTLY CONFIDENTIAL Ecoark Holdings, Inc.Exclusive Agency Agreement • December 30th, 2020 • Ecoark Holdings, Inc. • Crude petroleum & natural gas • New York
STRICTLY CONFIDENTIAL Histogen Inc. 10655 Sorrento Valley Road, Suite 200 San Diego, CA 92121 Attn: Richard W. Pascoe, Chief Executive Officer Dear Mr. Pascoe:Exclusive Agency Agreement • December 29th, 2020 • Histogen Inc. • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) constitutes the agreement between Histogen Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connect
STRICTLY CONFIDENTIAL Xenetic Biosciences, Inc.Exclusive Agency Agreement • December 14th, 2020 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • New York
SunHydrogen, Inc.Exclusive Agency Agreement • December 3rd, 2020 • Sunhydrogen, Inc. • Semiconductors & related devices • New York
STRICTLY CONFIDENTIAL Histogen Inc. 10655 Sorrento Valley Road, Suite 200 San Diego, CA 92121 Attn: Richard W. Pascoe, Chief Executive Officer Dear Mr. Pascoe:Exclusive Agency Agreement • November 12th, 2020 • Histogen Inc. • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) constitutes the agreement between Histogen Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connect
STRICTLY CONFIDENTIAL Spherix Incorporated One Rockefeller Plaza, 11th Floor New York, NY 10020 Attn: Anthony Hayes, Chief Executive Officer Dear Mr. Hayes:Exclusive Agency Agreement • August 26th, 2020 • Aikido Pharma Inc. • Services-commercial physical & biological research • New York
This letter agreement (this “Agreement”) constitutes the agreement between Spherix Incorporated (the “Company”) and H.C. Wainwright &. Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any of (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in conne
STRICTLY CONFIDENTIAL Akers Biosciences, Inc.Exclusive Agency Agreement • August 13th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
STRICTLY CONFIDENTIAL Emerald Bioscience, Inc.Exclusive Agency Agreement • July 28th, 2020 • Emerald Bioscience, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Immuron Limited Level 3, 62 Lygon Street Carlton South, Victoria 3053 Australia Attn: Jerry Kanellos, Ph.D., Chief Executive OfficerExclusive Agency Agreement • July 23rd, 2020 • Immuron LTD • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) constitutes the agreement between Immuron Limited (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in conne
Certain confidential information contained in this document, marked by brackets and asterisk, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed.Exclusive Agency Agreement • July 6th, 2020 • ReWalk Robotics Ltd. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This letter agreement (this “Agreement”) constitutes the agreement between ReWalk Robotics Ltd. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company (the “Securities”), including, but not limited to, restructuring of the outstanding warrants of the Company (a “Warrant Restructuring”), during the Term (as hereinafter defined) of this Agreement (each, an “Offering”). The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company
STRICTLY CONFIDENTIAL Aeterna Zentaris Inc.Exclusive Agency Agreement • June 30th, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Kitov Pharma Ltd. One Azrieli Center (Round Tower)Exclusive Agency Agreement • June 25th, 2020 • Kitov Pharma Ltd. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL China Jo-Jo Drugstores, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City People’s Republic of China 310008 Attn: Lei Liu, Chief Executive OfficerExclusive Agency Agreement • June 2nd, 2020 • China Jo-Jo Drugstores, Inc. • Retail-drug stores and proprietary stores • New York
This letter agreement (this “Agreement”) constitutes the agreement between China Jo-Jo Drugstores, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement (each, an “Offering”). The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwr
STRICTLY CONFIDENTIAL Diffusion Pharmaceuticals Inc.Exclusive Agency Agreement • May 20th, 2020 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Kitov Pharma Ltd. One Azrieli Center (Round Tower)Exclusive Agency Agreement • May 8th, 2020 • Kitov Pharma Ltd. • Pharmaceutical preparations • New York
